Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2015 Jan 1;25(1):88-91. Epub 2014 Nov 7.

Novel azoles as potent and selective cannabinoid CB2 receptor agonists.

Author information

1
Ipsen Innovation, Department of Compound Discovery, 5 Avenue du Canada, 91940 Les Ulis, France. jeremiah.harnett@ipsen.com

Abstract

Novel azole compounds were prepared which demonstrated potent hCB2 binding activities with antioxidant activity for a selected compound. These compounds show good selectivity over the hCB1 receptor and are full agonists at the hCB2 receptor.

PMID:
25466197
DOI:
10.1016/j.bmcl.2014.11.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center